Detail intricate cellular Mechanism of Action.
Depict complex dual-binding trimer interactions accurately.
Avoid generic, uninspiring oncology animation tropes.
Delivered engaging, MLR-ready medical affairs asset.
Showed drug's potent cytotoxic efficacy clearly.
Demonstrated profound depletion of malignant B-cells.

The finished asset delivers an authentic "ah-ha" moment, serving as an unforgettable peer-to-peer educational tool for medical affairs teams globally.

Trusted by some of the world's leading pharmaceutical, biotech and medical communications teams - including AstraZeneca, Pfizer, Sanofi, Takeda, Lundbeck and Samsung Biologics.



















